About Macrodeep
New report 2026 AI SDR market benchmark: six platforms, eight workflow stages See the results →

Le rapport

Actualités vérifiées sur le financement, les sièges sociaux et les dirigeants des entreprises les plus innovantes au monde

121 rapports et plus encore

Mis à jour quotidiennement avec les dernières informations de marché
Fundraising
Vaderis Therapeutics

Vaderis Raises $152M Series B for Rare Vascular Disease Therapy

Vaderis Therapeutics closed a $152 million Series B co-led by Life Sciences at Goldman Sachs Alternatives and TCGX as it began the Phase 3 HEROIC study of engasertib in HHT.

SalesTools Research
Aug 11, 2026
2 min read•$152M
Fundraising
Mironid

Mironid Raises $46M Series B for Polycystic Kidney Disease Drug

Mironid raised a $46 million Series B supported by the Scottish National Investment Bank and existing investors to advance clinical development of its ADPKD treatment.

SalesTools Research
Aug 5, 2026
2 min read•$46M
Fundraising
Diagonal Therapeutics

Diagonal Therapeutics Raises $125M Series B | Antibody Therapeutics

Biotech startup Diagonal Therapeutics secures $125 million Series B for rare genetic disease treatments.

SalesTools Research
Jan 7, 2026
0 min read•$125M
Pharmaceutical
Biogen Inc

Biogen Inc Headquarters - Office Location & Address

Discover Biogen Inc's headquarters at 225 Binney St, Cambridge, MA 02142. Biotechnology company pioneering science to deliver innovative medicines for neurodegenerative and rare diseases. Leader in multiple sclerosis treatments and Alzheimer's disease research with Aduhelm approval.. Learn about the office facilities and work environment.

Editorial Team
Oct 6, 2025
0 min read
Biotech
NanoMedicine Labs

NanoMedicine Labs Raises $460M Series C to Transform Healthcare

NanoMedicine Labs secures $460M in Series C funding at $5.8B valuation to advance phase iii clinical trials, scale manufacturing capabilities, and expand pipeline to rare diseases.

Editorial Team
Sep 14, 2025
0 min read•$460M
HealthTech
Syntis Bio

Syntis Bio raises $33M Series A

Syntis Bio raises $33M in Series A. Developing oral therapies for obesity diabetes and rare diseases...

Editorial Team
Jun 14, 2025
0 min read•$33M
Biotech
Adcytherix

Adcytherix Raises $122M Series A

Gene therapy company developing AAV-based treatments for rare genetic diseases with focus on CNS and ocular conditions

Emma Rodriguez
Oct 23, 2025
0 min read•$122M Series A
Biotechnology
Centogene

Centogene Headquarters - Office Location & Address

Discover Centogene's headquarters at Am Strande 7, Rostock, 18055. Rare disease diagnostics and therapeutics. Learn about the office facilities and work environment.

Editorial Team
Oct 5, 2025
0 min read
Biotechnology
Alexion

Alexion Headquarters - Office Location & Address

Discover Alexion's headquarters at 121 Seaport Blvd, Boston, MA 02210. Rare disease treatments. Learn about the office facilities and work environment.

Editorial Team
Oct 5, 2025
0 min read
Page 1

Affichage de 9 rapports • Page 1 • Catégorie : all

Restez en avance sur le marché

Recevez des insights hebdomadaires dans votre boîte de réception. Pas de spam, juste de l'intelligence.